LILRB1 and neoplasm: MHC class I component β2-microglobulin which is expressed on the surface of tumor cells, and its receptor, leukocyte immunoglobulin like receptor subfamily B member 1 (LILRB1), expressed on membrane of macrophages provides another therapeutic target.